CBLB and gastric cancer: To understand the detailed mechanism of Cbl‐b and c‐Cbl influencing TRAIL sensitivity in gastric cancer cells, we used plasmids with siRNA targeting Cbl‐b or c‐Cbl to knockdown Cbl‐b and c‐Cbl in gastric cancer cells.